MedPath

The effect of Alhagi maurorum distillate on renal and upper ureteral stones expulsion after Extracorporeal shock wave lithotripsy (ESWL): randomized clinical trial

Phase 3
Recruiting
Conditions
kidney stone.
Calculus of kidney and ureter
Registration Number
IRCT20150511022218N6
Lead Sponsor
eyshabour University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
140
Inclusion Criteria

Signing consent form
Age between 18 and 60 years
Stones with a diameter between 5-20 mm
Stones in the pelvis, middle and upper calyx (except lower calyx)

Exclusion Criteria

The patient's unwillingness to continue cooperating
Pregnancy
Uncontrolled urinary tract infection
Patients with coagulation problems
Severe spinal deformities
Patients with gastric ulcer problem (because the use of painkillers exacerbates this problem)
Severe hydronephrosis
Inadequate renal function (creatinine above 2 mg / dL)
BMI above 30
ESWL history unsuccessful
History of urinary tract surgery
Abdominal aortic and renal artery aneurysms
Patients taking alpha blocker or calcium blocker

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of the stone expulsion. Timepoint: Interventions will begin the day before the ESWL process and will continue daily until the stone is expelled. Stone removal In this study, we define complete stone removal or the remaining broken pieces of stone less than 3 mm during the two weeks to three months after the procedure. Method of measurement: En Using a checklist that includes: Clinical examination, patient interview, and ultrasound.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath